amgen weight loss news - Search News

Amgen, Weight Loss

Newsweek on MSN · 34m

Amgen Drug Delivers More Weight Loss Than Competitors

A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as Ozempic and Wegovy, according to the results of a recent trial. Trial participants who were obese or overweight lost an average of 20 percent of their body weight in 12 months without their weight loss plateauing,

MarketWatch on MSN · 7h

Amgen’s stock may see worst day in 24 years as weight-loss-drug data underwhelms

Amgen Inc.’s stock was down 7% Tuesday, after the company said a mid-stage trial of its weight-loss treatment MariTide showed up to 20% average weight loss at 52 weeks. Analysts were expecting the treatment to achieve an average weight loss of about 20% to 25% after one year,

Amgen's weight-loss drug fails to impress in study; shares plunge

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 people who were overweight or obese, the company said on Tuesday.

1d

Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed

Amgen (AMGN) reported today the highly anticipated results of a mid-stage trial of its experimental weight loss drug and ...

1h

Amgen price target lowered to $330 from $360 at RBC Capital

RBC Capital analyst Gregory Renza lowered the firm’s price target on Amgen (AMGN) to $330 from $360 and keeps an Outperform rating on the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results